title: MiR-223 suppresses cell proliferation by targeting IGF-1R.
abstract: To study the roles of microRNA-223 (miR-223) in regulation of cell growth, we established a miR-223 over-expression model in HeLa cells infected with miR-223 by Lentivirus pLL3.7 system. We observed in this model that miR-223 significantly suppressed the proliferation, growth rate, colony formation of HeLa cells in vitro, and in vivo tumorigenicity or tumor formation in nude mice. To investigate the mechanisms involved, we scanned and examined the potential and putative target molecules of miR-223 by informatics, quantitative PCR and Western blot, and found that insulin-like growth factor-1 receptor (IGF-1R) was the functional target of miR-223 inhibition of cell proliferation. Targeting IGF-1R by miR-223 was not only seen in HeLa cells, but also in leukemia and hepatoma cells. The downstream pathway, Akt/mTOR/p70S6K, to which the signal was mediated by IGF-1R, was inhibited as well. The relative luciferase activity of the reporter containing wild-type 3'UTR(3'untranslated region) of IGF-1R was significantly suppressed, but the mutant not. Silence of IGF-1R expression by vector-based short hairpin RNA resulted in the similar inhibition with miR-223. Contrarily, rescued IGF-1R expression in the cells that over-expressed miR-223, reversed the inhibition caused by miR-223 via introducing IGF-1R cDNA that didn't contain the 3'UTR. Meanwhile, we also noted that miR-223 targeted Rasa1, but the downstream molecules mediated by Rasa1 was neither targeted nor regulated. Therefore we believed that IGF-1R was the functional target for miR-223 suppression of cell proliferation and its downstream PI3K/Akt/mTOR/p70S6K pathway suppressed by miR-223 was by targeting IGF-1R.
authors.affiliation: Department of Biochemistry and Molecular Biology, Key Lab of Glycoconjugate Research, Ministry of Public Health, Shanghai Medical College, Fudan University, Shanghai, China.
authors.forename: Cheng You
authors.initials: CY
authors.lastname: Jia
authors.forename: Hui Hui
authors.initials: HH
authors.lastname: Li
authors.forename: Xu Chao
authors.initials: XC
authors.lastname: Zhu
authors.forename: Yi Wei
authors.initials: YW
authors.lastname: Dong
authors.forename: Da
authors.initials: D
authors.lastname: Fu
authors.forename: Qian Lei
authors.initials: QL
authors.lastname: Zhao
authors.forename: Wei
authors.initials: W
authors.lastname: Wu
authors.forename: Xing Zhong
authors.initials: XZ
authors.lastname: Wu
mesh_terms: D049109:Cell Proliferation; D055785:Gene Knockdown Techniques; D006367:HeLa Cells; D006801:Humans; D035683:MicroRNAs / Q000378:metabolism / Q000502:physiology*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D017526:Receptor, IGF Type 1 / Q000235:genetics / Q000378:metabolism*; D019893:Ribosomal Protein S6 Kinases / Q000378:metabolism; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism
chemical_list: D035683:MicroRNAs; D051057:Proto-Oncogene Proteins c-akt; D017526:Receptor, IGF Type 1; D019893:Ribosomal Protein S6 Kinases; D058570:TOR Serine-Threonine Kinases; C525067:MIR223, human; C546842:MTOR protein, human
references.citation: Brain Pathol. 2010 Nov;20(6):1042-54
references.pmid: 20557304
references.citation: Cell. 2005 Dec 2;123(5):819-31
references.pmid: 16325577
references.citation: Cancer Res. 2008 Oct 1;68(19):8183-8
references.pmid: 18829578
references.citation: Drug Resist Updat. 2008 Feb-Apr;11(1-2):32-50
references.pmid: 18166498
references.citation: Haematologica. 2010 May;95(5):819-28
references.pmid: 19951971
references.citation: Cell. 2007 May 4;129(3):617-31
references.pmid: 17482553
references.citation: Methods Mol Biol. 2010;614:175-85
references.pmid: 20225044
references.citation: Cancer Cell. 2007 Nov;12(5):457-66
references.pmid: 17996649
references.citation: Science. 2004 Jan 2;303(5654):83-6
references.pmid: 14657504
references.citation: Nucleic Acids Res. 2005 Nov 27;33(20):e179
references.pmid: 16314309
references.citation: J Med Chem. 2009 Aug 27;52(16):4981-5004
references.pmid: 19610618
references.citation: Leuk Res. 1989;13(10):869-74
references.pmid: 2586142
references.citation: Science. 2003 Mar 7;299(5612):1540
references.pmid: 12624257
references.citation: Gastroenterology. 2008 Jul;135(1):257-69
references.pmid: 18555017
references.citation: Chin Med J (Engl). 1991 Jan;104(1):32-5
references.pmid: 1879193
references.citation: Nat Cell Biol. 2009 Mar;11(3):228-34
references.pmid: 19255566
references.citation: J Biol Chem. 2002 May 3;277(18):15600-6
references.pmid: 11877395
references.citation: Curr Opin Genet Dev. 2009 Jun;19(3):230-6
references.pmid: 19467855
references.citation: Nat Genet. 2003 Mar;33(3):401-6
references.pmid: 12590264
references.citation: Haematologica. 2009 Apr;94(4):479-86
references.pmid: 19278969
references.citation: Urol Oncol. 2007 Sep-Oct;25(5):387-92
references.pmid: 17826655
references.citation: Mol Cancer. 2008 Apr 28;7:35
references.pmid: 18442408
references.citation: J Biol Chem. 2010 Nov 5;285(45):34439-46
references.pmid: 20826802
references.citation: Clin Chim Acta. 2009 Jul;405(1-2):119-26
references.pmid: 19394320
references.citation: Cancer Res. 2009 Feb 1;69(3):1135-42
references.pmid: 19155302
references.citation: Cell Biol Int. 2006 Aug;30(8):672-80
references.pmid: 16806999
references.citation: Nature. 2008 Feb 28;451(7182):1125-9
references.pmid: 18278031
references.citation: Int J Cancer. 2004 Jul 1;110(4):504-10
references.pmid: 15122582
references.citation: Chin Med J (Engl). 1996 Apr;109(4):295-9
references.pmid: 8758291
references.citation: Cell. 2004 Jan 23;116(2):281-97
references.pmid: 14744438